Meco Diagnostics

Developer of predictive biomarker tests for breast cancer care

placeSan Diego, California, United States calendar_todayFounded 2022 groups1 employees language mecodiagnostics.com

Social engagement

Social engagement: 763 social following, 1 post in the last 12 months — around the industry typical range.

Investor mix

3 investors on record; lead investors include EvoNexus.

Investor typeCountShare
Venture capital267%
Accelerator & incubator133%
Coming soon